Tinea Versicolor: Clinical Trials

4 trials for Tinea Versicolor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 not yet recruiting. 4 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Completed 3, Not yet recruiting 1
Phase 11Not yet recruiting 1

Follow Tinea Versicolor: new trials by email Literature Review of Tinea Versicolor trials Research Report on Tinea Versicolor

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparative Efficacy of Topical 1% Clotrimazole vs Oral Itraconazole in the Treatment of Pityriasis Versicolor
Topical 1 % clotrimazole twice daily 2 weeks, Oral itraconazole 200mg daily for 5 days - Pityriasis Versicolor
Phase 1 / Phase 2Not yet recruitingCombined Military Hospital Abbottabad862026-02-022026-01-12
A Trial to Evaluate the Safety and Antimicrobial Efficacy of DBI-002 Probiotic in Adults With Tinea Versicolor
DBI-002 probiotic gel, Aqueous gel - Tinea Versicolor
Phase 2CompletedDermBiont, Inc.342021-03-162025-07-03
Clinical Assessment of Voriconazole Self Nano Emulsifying Drug Delivery System Intermediate Gel
voriconazole gel once daily, voriconazole gel twice daily, placebo - Tinea Versicolor
Phase 2CompletedSara Botros302018-02-152019-10-01
Clinical Assessment of Itraconazole Self Nano Emulsifying Drug Delivery System Intermediate Gel
itraconazole gel once daily, itraconazole gel twice daily, placebo - Tinea Versicolor
Phase 2CompletedSara Botros302018-02-152019-10-01

Broader conditions

Bacterial Infections and Mycoses (4)  ·  Dermatomycoses (4)  ·  Infections (4)  ·  Mycoses (4)  ·  Skin Diseases (4)  ·  Skin Diseases, Infectious (4)  ·  Skin and Connective Tissue Diseases (4)

Interventions

BANG polymer gel (1)  ·  Itraconazole (1)

Sponsors

Sara Botros (2)  ·  Combined Military Hospital Abbottabad (1)  ·  DermBiont, Inc. (1)

Countries

Egypt (2)  ·  El Salvador (1)

Top investigators

Sara R Botros, bachelor of clinical pharmacy (2)  ·  David Zepeda, MD (1)